2.10
+0(+0.00%)
Currency In USD
| Previous Close | 2.1 |
| Open | 2.09 |
| Day High | 2.1 |
| Day Low | 2.09 |
| 52-Week High | 4.74 |
| 52-Week Low | 0.95 |
| Volume | 21,416 |
| Average Volume | 255,868 |
| Market Cap | 36.38M |
| PE | -0.24 |
| EPS | -8.58 |
| Moving Average 50 Days | 2.08 |
| Moving Average 200 Days | 2.54 |
| Change | 0 |
If you invested $1000 in Mural Oncology plc (MURA) since IPO date, it would be worth $552.63 as of November 12, 2025 at a share price of $2.1. Whereas If you bought $1000 worth of Mural Oncology plc (MURA) shares 1 year ago, it would be worth $596.59 as of November 12, 2025 at a share price of $2.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
GlobeNewswire Inc.
Oct 24, 2025 8:25 PM GMT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION WALTHAM, Mass. and DUBLIN, Ireland, Oct. 24, 2
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
GlobeNewswire Inc.
Sep 23, 2025 11:52 PM GMT
WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 20
Mural Oncology Announces Number of Relevant Securities in Issue
GlobeNewswire Inc.
May 19, 2025 7:57 PM GMT
WALTHAM, Mass. and DUBLIN, May 19, 2025 (GLOBE NEWSWIRE) -- In accordance with Rule 2.12 of the Irish Takeover Panel Act 1997, the Irish Takeover Rules 2022 (the “Irish Takeover Rules”), Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-on